# OnCo record aza-001 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/aza-001/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "aza-001", "NCT00071799" ;
  schema:name "AZA-001"@en ;
  schema:description "AZA-001 was the trial that showed a drug could help people with higher-risk myelodysplastic syndromes live longer: azacitidine beat the best conventional care, and it has been the backbone of treatment for this disease ever since."@en ;
  schema:url <https://onco.cc/trials/aza-001/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00071799> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/mds-higher-risk/>, <https://onco.cc/cancers/mds/> ;
  onco:drugs <https://onco.cc/drugs/azacitidine/> ;
  onco:companies <https://onco.cc/companies/bms/> ;
  onco:people <https://onco.cc/people/pierre-fenaux/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-aza-001-fenaux-lancet-oncol-2009/> .